Unicorn AIM VCT's half-year NAV total return of 11.5% beat a falling AIM index, driven by a lucrative Hasgrove exit and big shareholder payouts.
This article covers information on Unicorn AIM VCT PLC.
LON:UAVUnicorn AIM VCT has put out a genuinely strong half-year update for the six months to 31 March 2026. The headline number is a net asset value total return per share of 11.5%, which looks even better when set against the FTSE AIM All-Share Index falling by 7.8% over the same period.
That matters because this is a Venture Capital Trust, or VCT – a tax-efficient listed fund that invests mainly in smaller growth companies. AIM has been a difficult hunting ground for years, so any VCT that can produce positive returns while the benchmark is falling is doing something right.
The big caveat is that this was not a boring, steady six months. It was driven heavily by one standout success – the partial sale of Hasgrove, now Maia TopCo, which transformed both performance and shareholder payouts.
| Key figure | Value | Why it matters |
|---|---|---|
| NAV total return per share | 11.5% | Strong positive return in a weak small-cap market |
| FTSE AIM All-Share Index return | -7.8% | Shows clear outperformance |
| Net assets | £178.9 million | Down from £194.4 million mainly due to cash distributions |
| NAV per share | 74.17p | Lower after large special dividends were paid out |
| Interim dividend declared | 2.0p per share | Ongoing income stream |
| Special dividend paid | 23.0p per share | Major return of capital from Hasgrove proceeds |
| Additional special dividend declared | 3.9p per share | More cash due in September 2026 |
| Offer for Subscription raised in period | £13.6 million after costs | Fresh capital for new investments |
At first glance, the drop in NAV per share from 90.28p at 30 September 2025 to 74.17p at 31 March 2026 looks rough. But in this case, that is mostly the effect of paying out a lot of cash to shareholders rather than a simple collapse in value.
During the period, the company paid a 23.0p per share special dividend and a 3.5p per share final dividend for the 2025 year. It has also now declared a further 3.9p per share special dividend and a 2.0p per share interim dividend, both due to be paid in September 2026.
This is exactly why the company highlights total return, which adds dividends back in. My read is simple: a lower NAV is not automatically bad news when it comes after a profitable exit and a big cash return to investors. In this case, the total return figure tells the real story far better than the raw NAV move.
Related
Polar Capital Technology Trust sees 102% NAV growth in FY2026, beating its benchmark by 47 points thanks to AI and semiconductor exposure.
JoshuaJuly 10, 2026
Last updated
Category
InvestingViews
9 viewsLikes
No ratings yet
Last updated:
The engine behind this result was Maia TopCo, formerly Hasgrove. Unicorn AIM VCT realised total proceeds of approximately £88 million from the transaction, while still retaining a £22 million rollover equity stake as a continuing minority shareholder.
That is a huge result. The company says it represents a return of circa sixty-eight times original cost over 19 years, which is the sort of number that can define a VCT’s long-term track record.
The deal valued the business at an enterprise value of approximately £320 million. More importantly for retail investors, it shows what patient investing can look like when it works – backing a business early, sticking with it through years of development, and eventually turning that into real cash.
That cash did not just sit on the balance sheet either. It was returned to shareholders quickly, which is a big positive for anyone who owns a VCT for a mix of capital growth and income.
It was not only Hasgrove doing the heavy lifting, although it was clearly the main act. Aurrigo International added £3.43 million, Schroders added £1.35 million, Idox added £1.00 million, and Hardide added £0.76 million.
There were also notable disappointments. Cohort knocked off £2.42 million, The Property Franchise Group £2.1 million, Renalytix £1.94 million, Tracsis £1.90 million and MaxCyte £1.59 million.
That is the less cheerful bit of the report. The company booked £41.225 million of realised gains on investments, but also suffered £20.145 million of net unrealised losses. So while the exit story was excellent, the wider portfolio still had its bruises.
This was a very cash-active period. Total dividends paid came to £57.049 million, including the 23.0p per share special dividend that alone distributed approximately £50 million to shareholders.
On top of that, the Offer for Subscription launched on 26 January 2026 raised £13.6 million after costs during the period, with a further £12.2 million after costs received since the period end. The Chair also states total funds raised reached £24.2 million by 5 April 2026.
That matters because VCTs need fresh capital to keep investing, especially after large exits. The company also allotted 12,024,066 Ordinary Shares under its dividend reinvestment scheme, which helped retain capital within the fund for those shareholders who chose to roll dividends back in.
Share buybacks continued too, with 2,875,341 Ordinary Shares bought back for cancellation during the period. That represented 1.3% of the shares in issue at 30 September 2025.
As at 31 March 2026, 53.1% of assets were in AIM traded investments and 13.6% in unquoted holdings. Another 18.8% sat in other funds, while cash and other assets accounted for 1.9%.
The company had no borrowings, which I see as a quiet positive in a volatile market. It also held £5.1 million in cash and cash equivalents, alongside meaningful holdings in money market funds and listed investments, giving it flexibility while it waits for suitable qualifying deals.
There is also a useful regulatory angle here. The Board says changes to VCT rules have doubled the investment limits for qualifying investee companies, widening the pool of businesses it can back. That could improve the quality and maturity of future investments.
The sting in the tail is that upfront tax relief for new VCT investors has been cut from 30% to 20%. The Board is right to flag that as disappointing, because it may make fundraising harder across the sector in future.
Overall, this is a good half-year report. Unicorn AIM VCT beat its benchmark comfortably, monetised a long-held winner brilliantly, and returned substantial cash to shareholders without stretching the balance sheet.
The flip side is that the result is concentrated. Hasgrove was the star, and the portfolio still contains clear weak spots, particularly where trading momentum, sector sentiment or funding pressure have gone the wrong way.
The Board is also unusually blunt about geopolitical risk, especially the impact of conflict in the Middle East and the threat of higher energy prices. That is worth taking seriously because smaller companies are often more exposed to economic shocks than larger blue-chip names.
My view is that existing shareholders will probably be pleased with this update. For anyone looking at the stock today, the report shows exactly why VCT returns can be lumpy but rewarding – one great exit can change the picture dramatically, but you still need patience and a strong stomach.
Impax Q3 AUM rises to £23.3bn despite £1.7bn net outflows, driven by market gains and strong investment performance.
JoshuaJuly 10, 2026
MJ Gleeson FY2026 trading update: steady profits, mixed home sales with operational restructuring improving outlook.
JoshuaJuly 10, 2026
No comments yet - start the conversation.